BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34273249)

  • 1. Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.
    Bian SX; Hwang L; Hwang J; Ragab O; In GK; Peng D; Lin E
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1049-1061. PubMed ID: 34273249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
    Huayllani MT; Restrepo DJ; Boczar D; Avila FR; Bagaria SP; Spaulding AC; Rinker BD; Forte AJ
    Anticancer Res; 2020 Jun; 40(6):3411-3415. PubMed ID: 32487638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
    Cheraghlou S; Ugwu N; Girardi M
    JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
    Huang K; Fan J; Misra S
    J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
    Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
    Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
    Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
    Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
    J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Gloves-and-socks" melanoma: does histology make a difference?
    Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
    Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma.
    Susok L; Gambichler T
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):497-502. PubMed ID: 33856527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
    Bradford PT; Goldstein AM; McMaster ML; Tucker MA
    Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
    Pavri SN; Han G; Khan S; Han D
    J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
    Kuchelmeister C; Schaumburg-Lever G; Garbe C
    Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
    Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
    Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acral Lentiginous Melanoma.
    Goydos JS; Shoen SL
    Cancer Treat Res; 2016; 167():321-9. PubMed ID: 26601870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.
    Lee TL; Liao YH; Liau JY; Sheen YS
    Sci Rep; 2021 Oct; 11(1):21012. PubMed ID: 34697327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
    Tas F; Erturk K
    Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
    Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.